» Articles » PMID: 1701733

Morphine and Substance P Release in the Spinal Cord

Overview
Journal Exp Brain Res
Specialty Neurology
Date 1990 Jan 1
PMID 1701733
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In anaesthetised cats, antibody microprobes were used to measure the release of immunoreactive substance P (irSP) in the lumbar dorsal horn during noxious cutaneous stimulation or high-intensity electrical stimulation of a hind limb nerve. The major region of irSP release detected was centered on the substantia gelatinosa, with lesser release at the dorsal cord surface. Release at these sites was unchanged by systemic administration of morphine, or of morphine followed by naloxone. During superfusion of the dorsal cord surface with high concentrations of morphine, irSP release in the substantia gelatinosa region was slightly reduced and surface release was not observed, effects not reversed by systemic naloxone administration. The results suggest that the analgesic action of morphine does not involve reduced release of SP in the spinal cord.

Citing Articles

C2 spinal cord stimulation induces dynorphin release from rat T4 spinal cord: potential modulation of myocardial ischemia-sensitive neurons.

Ding X, Hua F, Sutherly K, Ardell J, Williams C Am J Physiol Regul Integr Comp Physiol. 2008; 295(5):R1519-28.

PMID: 18753268 PMC: 2584856. DOI: 10.1152/ajpregu.00899.2007.


mu-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn.

Aicher S, Punnoose A, GOLDBERG A J Neurosci. 2000; 20(11):4345-54.

PMID: 10818170 PMC: 6772648.


Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.

Malcangio M, Bowery N Br J Pharmacol. 1994; 113(2):635-41.

PMID: 7530576 PMC: 1510144. DOI: 10.1111/j.1476-5381.1994.tb17037.x.


Analgesic doses of morphine do not reduce noxious stimulus-evoked release of immunoreactive neurokinins in the dorsal horn of the spinal cat.

Lang C, Duggan A, Hope P Br J Pharmacol. 1991; 103(4):1871-6.

PMID: 1655145 PMC: 1908214. DOI: 10.1111/j.1476-5381.1991.tb12344.x.


Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P.

Kessler W, Kirchhoff C, Reeh P, Handwerker H Exp Brain Res. 1992; 91(3):467-76.

PMID: 1282891 DOI: 10.1007/BF00227842.

References
1.
Hendry I, Morton C, Duggan A . Analysis of antibody microprobe autoradiographs by computerized image processing. J Neurosci Methods. 1988; 23(3):249-56. DOI: 10.1016/0165-0270(88)90009-x. View

2.
Ljungdahl A, Hokfelt T, Nilsson G . Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals. Neuroscience. 1978; 3(10):861-943. DOI: 10.1016/0306-4522(78)90116-1. View

3.
Mudge A, Leeman S, Fischbach G . Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci U S A. 1979; 76(1):526-30. PMC: 382975. DOI: 10.1073/pnas.76.1.526. View

4.
Kuraishi Y, Hirota N, Sugimoto M, Satoh M, Takagi H . Effects of morphine on noxious stimuli-induced release of substance P from rabbit dorsal horn in vivo. Life Sci. 1983; 33 Suppl 1:693-6. DOI: 10.1016/0024-3205(83)90597-0. View

5.
Duncan D, Morales R . Relative numbers of several types of synaptic connections in the substantia gelatinosa of the cat spinal cord. J Comp Neurol. 1978; 182(4):601-10. DOI: 10.1002/cne.901820403. View